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ABSTRACT: Α pacient with acute leukemia and her
family including four HLA-identical sibüngs were ana-
lyzed to select a donor who was not only HLA- but also
minor histocompatibility (mH) antigen compatible for al-
logeneic bone marrow transplantation (BMT) The HLA-
A2 restncted mH antigen-specific HA-1, -2, -4, and -5
cytotoxic T-lymphocyte (CTL) clones were used to type
the family members for expression of these mH antigens
The patient and one HLA-identical sibling were compati-
ble for these mH antigens This sibling was selected as
the bone marrow donor The patient engrafted promptly
but developed acute and chronic graft-versus-host dis-
ease To study the presence of other mH antigen dispari-
ties between recipient and donor, host-versus-graft CTL
lines and clones were generated by Stimulation of recipi-
ent penpheral blood lymphocytes (PBLs) with donor
bone marrow cells, and graft-versus-host CTL lines were
generated after BMT by Stimulation of PBLs of donor
ongin with recipient bone marrow cells These CTL lines
were cytotoxic to cells from the bone marrow donor and
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from the recipient, respectively, and to cells from several
other family members T-cell lines, generated from the
patient after BMT by Stimulation of recipient-denved
PBLs with donor bone marrow cells, exhibited no specific
cytotoxicity to donor or recipient cells Chimensm stud-
les after BMT revealed that the PBLs and T-cell lines
generated after BMT were of donor ongin CTL lines
that were generated from PBLs from the three other
HLA-identical siblings in this family by Stimulation with
HLA-identical donor bone marrow cells also exhibited
cytotoxicity to cells from several family members Our
results show that in addition to companbility for HA-1,
-2, -4, and -5 between the recipient and the donor, other
mH antigen disparities existed between all HLA-identical
siblings, lllustrating the high degree of polymorphism of
mH antigens and therefore the difficulty of finding mH
antigen-compatible donor—recipient pairs even when
more than one HLA-identical sibling IS present within a
family Human Immunology 37, 221-228 (1993)
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INTRODUCTION
HLA-identical bone marrow transplantation (BMT) is
frequently complicated by acute graft-versus-host dis-
ease (aGvHD). This complication is thought to be ιη-
duced by donor Τ cells from the graft that specifically
Human Immunology 37, 221-228 (1993)
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ebnes with the same specificity CTL clone 10E8 is a
representative examplc of these clones that recognized
cells from the bone marrow donor and from siblmgs 4
and 7 Phenocypic analysis of the clones by FACS scan
ning, using anci-CD3, -CD4, and CD8 monoclonal an
nbodies (Becton-Dickinson, Mountain View CA
USA) showed that they were CD3+CD8 f These
results show that CTL lmes can be generated with van
ous mH antigen specificittes from pre BMT recipient
PBLs by Stimulation with donor BMMNCs
Recognttion of celh from famtly members by GvH CTL
lmes Table 3 shows that the CTL hnes generated from
PBLs collected at several intervals after BMT and stimu
lated with irradiated recipient pretransplant BMMNCs
differentially recognized cells from other family mem
bers, which suggested the presence of different mH
antigen speaficities in the GvH CTL hnes
Recogmtion of cells from family members by the sibling 3 4
and 5—anttdonnr CTL hnes CTL hnes were generated
from PBLs from three other HLA identical siblings by
Stimulation with irradiated donor BMMNCs Table 4
shows that these CTL lincs differtncially recognized
cells from other family membtrs CTL hnc 'i—intidonor
only lysed to a hmitcd extend LBV LCLs from tht do
nor but not IL 2 blasts
Lack of donor speafic recognition by po\t BMI anttdonot
bone marrow Τ ceil lincs Γο investigate the presence of
residual potential donor directed CTLs in the penph
eral blood of the recipient1 after BMT PBLs colkctcd
on days +14 +19 +27 -MO +60 and +I80wcrc
stimulated with irradiated donor BMMNCs 1 cell hnes
generated from PBLs collected on days H4 +19 Η 27
and +40 were neithcr cytotoxic for teils from the recip
lent nor for cells from the bone mirrow donor Cyto
toxicity against EBV LCLs but not IL 2 blists from rc
cipient and bone marrow donor were detected in the
Τ cell hnes generated from PBLs collected on days +60
and +180 and that had been stimulated with donor
BMMNCs only The observed cytotoxicity was not do
nor specific however since autologous cclls ilso were
recognized (data not shown) Determination offne ori
gin of the Γ celi lmes generated after BMT showed that
they all were donor derived (1 ig 1)
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DISC USS1ON
1JLA aicntical ΒΜΊ m.iy be tompheated by stvtrc
ciGvHD orgraft rejeenon dcspitc optimal matt hing for
HLA tidss 1 and II .mtigtns 11-7} lioth comphcations
arc tliought CP bc the rcsult of the rctognition of mH
iintigcns by immunoconipLtcnt Τ lymphotytts from do-
nor or rcapjcnr οπ/jjn, rtsptctivtJj' [2 H] MJIKJI his-
toiompatibtht^ antigtns arc thoughr to bc pcpndes de
nvcd from ccllular protems [26] that ire bound in ehe
groove of major histocomparibility cornplcx (MH( )
molecuics This MHC moltculc-pcptidc compltx can
be rtcognized by allorcactivc I lymphocyrcs [27] Con-
sequcntly, matchmg f(jr ml! antmens between tlonor
riGÜRt 1 RfLPanal>sis idaptcd ioi iJ( R ampliiicatinn,
of PBLs from the bonc mairow donor ind ehe rmpicm, ind
of the posttrinsplant uuulonor bone mirrow Τ cell lines Fht
biimh icprescnt PC R amplifitd DNA l)Cuk\ marked f <UL
tilgested with the restriction tn/jmc Ava I! and ineks m irkctt
ire undigested lrack\ I and 2 arc donor celi denved and
proiiuce onfy onc band, uhercas haiks ·> and 4 are rt.cipK.nr
teil denvcti and pioducc two bands when tii^ Lsreti with Ava 11
(track 4) Rccipient ind donor etlis were colletrcd liefore
BM Γ Tracks 5 — 16 are· denved from rccipient post BMT anti
donor DMMNC Τ ccll hncs, genertted from retipienr PBLs
tollecteU J4-180 days aftcr BMT
and recipient may decreaso the incidence antl seventy üf
aGvHD and graft rcjection
In mice, morc tban 50 mHgenes have beert describul
[28] In humans, several authors have desenbed mH
antigen spccific CTLs in patients after multiple blood
tramfusions and bone marrow and kidney transplanta-
tion [2, 29-^2] Mappmg of the gene lou has been
suctessful oniy for the male mH antigen Η Υ, both in
humans and mice 13 3, 34), and for MTF, a mouse mH
antigen entoded by mitochondna! DNA [35] lf the
polymorphism of immunogemc human mH antigens is
as exrendctl -is in mice, (he chanecs of fwding donor-
rcuptent pairs identica! for both major and minor histo-
tompatibility antigens may be limited
Previously, we have shown that, pnor to BMT, rccipi-
ent-antidonor cytotoxicity was demonstrated in seven
of ten HLA-i'ientical donor-recipient pairs [21] In the
present stud>, we show that although donor and reupi
ent were matched for the mH antigens HA-1, -2, -4,
and -5, additional cytotoxic reactivity against other, as
yet uneicfined, mH antigens was present between chese
two sibl'.igs, both in the GvH and the HvG directions
The dnferences in rccogmtion patterns between the
HvG fjarent line and its sublmes and between the GvH
lines generated at dtfferent time intervals after Β Μ Γ
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may reflect differences in the frequencies of the vanous
mH antigen-specific CTL clones present in the CTL
lines The differential reactivity of the post-BMT GvH
CTL lines may reflect in vivo sensitization of donor Τ
cells againsc mH antigens These mH antigens may be
sequentially expressed on recipient stimulator cells,
e g , due to sequential infections by pathogens that up-
regulate expression of vanous self-mH antigens In ad-
dition, when PBLs from the three other HLA-identical
sibhngs were stimulated with irradiated donor
BMMNCs, CTL lines were generated that also recog-
mzed mH antigens expressed on cells from family mera-
bers These results lllustrate multiple mH antigen dis-
panties between the HLA-identical family members
Despite the presence of host-antidonor cytotoxic re-
activity pnor to BMT, no graft rejection oecurred No
residual recipient cells were demonstrated in penpheral
blood and bone rnarrow collected from the recipient by
chimensm studies after BMT These findings were in
aecordance with the inability to generate recipient—anti-
donor CTL lines from posttransplant PBLs, suggesting
chat no functtonal alloreactive recipient Τ lymphocytes
were present after BMT These findings can be ex-
plained by the eradication of recipient-immunocompe-
tent Τ cells by the condmomng regimen [36, 37), by
their suppression by Τ cells from the graft {3], or by the
posttransplant immunosuppressive therapy [38] Un-
complicated engraftment despite in vitro HvG reactiv-
ity pnor to BMT agrees with a previous report [21] in
which we desenbe that, in seven of ten HLA-identical
donor—recipient pairs, recipient—antidonor CTL lines
were generated before BMT None of these patients
showed signs of graft failure or graft rejection
GvHD was not prevented by matching for expres-
sion of the mH antigens HA-1, -2, A, and -5, suggesting
that also in the GvH direction additional mH antigen
dispanties were present between donor and recipient
Our in vitro results with T-cell lines, generated by Stim-
ulation of PBLs collected at several intervals after BMT
with recipient pre-BMT BMMNCs, paralleled the in
vivo observed GVH reactivity Van Eis et al [39] could
not demonstrate a clear correlation between the inci-
dence of GvHD and the abihty, or inability, to generate
antihost CTL lines after BMT Together the results re-
ported here and those by Van Eis et al indicate that
most donor—recipient pairs are mH antigen disparate,
but that there is not necessanly a relation between the
abihty, or inability, to generate CTL lines that lyse re-
cipient or donor cells and the oecurrence of GvHD or
graft rejection
Presently, matching for mH antigens is not feasible
due to their number and polymorphism Quantitative,
more than merely qualitative, differences in mH anti-
gen-specific T-cell responses between recipients and
their potential donors may be corrciated with graft rt
jection or GvHD Quantitative difftrenecs may bc esti-
mated by using hmiting dilution assays to deterrmne-
CTL or T-helper-cell precursor frequencies as has been
desenbed in unrelated HLA-matched donor-recipicnt
pairs or ailogeneic responder-stimulator pairs by
Kaminski et al [40, 4 1] and Deacock et al [42], respec-
tively Adapting these protocols to the specific Situation
of HLA-identical sibhng BMT, e g , by usmg BMMNCs
as stimulator cells, may produce valuable Information
In conclusion, we have analyzed the mH antigen dis-
panty between HLA-identical and -nonidentical family
members of a patitnt with leukemia, and the possibility
of finding a sibhng bone marrow donor who was both
HLA and mH antigen compatible In addition to com-
patibihty for the mH antigens HA-1, -2, -4, and -5 be-
tween bone marrow donor and recipsent, dispanty for
multiple other mH antigens was demonstrated both in
the HvG and the GvH directions CTL lines were gen-
erated from PBLs from three other HLA identical sib
hngs by Stimulation with donor BMMNC s, also recog
nizing mH antigens expresseu1 ο η cells from family
members Donor—antirecipient, but no residual recipi
ent—antidonor, reactivity was demonstrated at several
intervals after BMT In view of these hndings, hnding
donor-recipient pairs that are HLA and mH antigen
identical is unhkely Quantitative, more than mc-rtly
qualitative, differences in the immune responses to mH
antigens between recipients and their potential donors
may more hkely determme the incidencc or scvtrity of
GvHD or graft rejection following Hl A-identical
BMT
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